Clinical trial
Immunogenicity and Reactogenicity of Fluarix™ (Influsplit SSW®) 2007/2008 in…
NCT00476307 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00476307 |
|---|---|
| Title | Immunogenicity and Reactogenicity of Fluarix™ (Influsplit SSW®) 2007/2008 in People 18 Years Old or Above |
| Official title | A Phase III Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix™ (Influsplit SSW®) 2007/2008 in People Aged 18 Years or Above |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Biological |
| Interventions | Fluarix™/Influsplit SSW® 2007/2008 |
| Enrollment | 120 |
| Start date | Jun 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | May 22, 2007 |
| Last update posted | Nov 4, 2016 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: